CTRI/2011/091/000140
Completed
Phase 3
A randomized, open label, comparative, multicentric, phase 3 clinical study to assess the efficacy and safety of Blonanserin tablets in comparison with Haloperidol tablets in patients suffering from schizophrenia - None
Overview
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Cadila Healthcare Ltd
- Enrollment
- 200
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1\.Patients between 18\-65 years of age.
- •2\.Patients with diagnosis of schizophrenia.
- •3\.Informed consent.
Exclusion Criteria
- •1\.Pregnancy and/or lactation.
- •2\.Patients with suicidal tendencies.
- •3\.Patients with relevant CNS disorders or history of such disorders.
- •4\.Patients with a history of neuroleptic malignant syndrome (NMS).
- •5\.Patients with uncontrolled diabetes or significant cardiovascular diseases.
- •6\.Patients with angle\-closure glaucoma, benign prostatic hyperplasia, urinary retention or paralytic ileus.
- •7\.Patients with significant renal or hepatic impairment, acute infections, leucopenia, hyperthyroidism or SIADH.
- •8\.Impoverished patients.
- •9\.Patients with an organic psychiatric disorder.
- •10\.History of hypersensitivity to study medication.
Investigators
Similar Trials
Completed
Phase 3
A clinical trial to study the effects of two drugs, fixed dose combination capsules of Celecoxib and Diacerein and fixed dose combination tablets of Aceclofenac and Diacerein in patients with osteoarthritis of knee and/or hip joints.Health Condition 1: M169- Osteoarthritis of hip, unspecifiedHealth Condition 2: null- Osteoarthritis of knee and/or hip jointsHealth Condition 3: M179- Osteoarthritis of knee, unspecifiedCTRI/2010/091/000053Cadila Healthcare Ltd200
Completed
Phase 3
A clinical trial to study effectiveness and safety of Fixed dose combination tablets of Hyoscine butylbromide & Mefenamic acid in patients suffering from paroxysmal spastic abdominal paiHealth Condition 1: R108- Other abdominal painHealth Condition 2: null- Paroxysmal spastic abdominal painCTRI/2011/091/000141Cadila Healthcare Ltd200
Completed
Phase 3
A clinical trial to study effectiveness and safety of Acrivastine capsules in comparison with Chlorpheniramine maleate tablets in patients suffering from allergic rhinitisHealth Condition 1: null- Allergic rhinitisHealth Condition 2: J309- Allergic rhinitis, unspecifiedCTRI/2010/091/001368Cadila Healthcare Ltd200
Unknown
Phase 4
To determine the efficacy and safety of a combination of Extended Release (ER) Niacin and Rosuvastatin as compared with Rosuvastatin alone in patients with Mixed Dyslipidemia.Health Condition 1: null- Mixed DyslipidemiaCTRI/2010/091/003016Troikaa Pharmaceuticals Ltd160
Completed
Phase 3
A clinical trial to study effectiveness and safety of Revaprazan tablets in comparison with Omeprazole capsules in patients suffering from Peptic Ulcer or Acute GastritisCTRI/2010/091/001055Cadila Healthcare Ltd200